Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07251660Not ApplicableNot Yet Recruiting

Comparison of Early Postoperative Outcomes Between Minimally Invasive Valve Surgery Via Right Thoracotomy and Conventional Valve Surgery Via Sternotomy.

Role: lead

NCT05290324Not ApplicableCompleted

Propofol or Midazolam for Sedation and Early Extubation Following Coronary Artery Bypass Graft Surgery

Role: lead

NCT04700215Not ApplicableUnknown

Comparison of BiPAP and ٰIS in Reducing Post CABG Pulmonary Complications

Role: lead

NCT05218161Not ApplicableUnknown

Hemodynamic Effect of Dexmedetomidine Alone With Dexmedetomidine Plus Ketamine Combination in CABG

Role: lead

NCT05004545Not ApplicableUnknown

Compare Hemodynamic Parameters of Propofol and Sevoflurane During CPB Time in Undergoing CABG to Avoid Lactate Level

Role: lead

NCT02303704Phase 2Completed

Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia

Role: lead

All 6 trials loaded